Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways

A Corrigendum to this article was published on 23 November 2001

Abstract

We investigated the role of radiation-induced mitogen activated protein kinase (MAPK) pathway activity in the regulation of proliferation, cell survival and vascular endothelial growth factor (VEGF) production in primary astrocytes and in T9 and RT2 glioblastoma cells derived from Fisher 344 rats. In these cells, ionizing radiation (2 Gy) caused activation of the MAPK pathway which was blocked by specific inhibitor drugs. Blunting of radiation-induced MAPK activity weakly enhanced radiation-induced apoptosis 24 h after exposure in RT2 cells. Furthermore, blunting of MAPK activation weakly enhanced the ability of radiation to reduce RT2 cell growth in clonogenic growth assays. These findings argue that inhibition of MAPK signaling reduces proliferation and enhances cell killing by ionizing radiation in transformed astrocytes. Proliferation and survival of cancer cells has been linked in vivo to enhanced expression of angiogenic growth factors. Recently we demonstrated that the gene product of a novel rodent radiation-responsive gene, progression elevated gene 3 (PEG-3), could enhance vascular endothelial growth factor (VEGF) promoter activity in rodent fibroblasts, leading to increased VEGF protein levels and tumorigenic behavior in vivo. Thus PEG-3 and VEGF expression could be expected to directly correlate with the oncogenic potential of transformed cells. RT2 cells expressed more PEG-3 and VEGF protein than T9 cells, and were more tumorigenic in vivo than T9 cells. Radiation activated the PEG-3 promoter via MAPK signaling and ectopic over-expression of PEG-3 enhanced both basal MAPK activity and basal VEGF promoter activity. Basal MAPK activity partially correlated with basal VEGF promoter activity and VEGF protein levels in primary astrocytes, T9 and RT2 cells. Radiation increased the activity of the VEGF promoter and VEGF protein levels in primary astrocytes, T9 and RT2 cells which were dependent upon MAPK function. Furthermore, inhibition of AP-1 transcription factor signaling by dominant negative c-Jun (TAM67) also significantly reduced basal, and to a lesser extent radiation-induced, VEGF promoter function in RT2 cells. Collectively, our data demonstrate that radiation-induced MAPK signaling can both protect cells from radiation-induced cell death as well as enhance protein levels of pro-angiogenic factors such as VEGF. Enhanced VEGF expression in RT2 cells may be mediated via MAPK and JNK pathway signaling which converges upon the AP-1 transcription factor complex.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Abbreviations

MAPK:

mitogen activated protein kinase

JNK:

c-Jun NH2-terminal kinase

VEGF:

vascular endothelial growth factor

PEG-3:

progression elevated gene-3.

References

  • Abbott DW, Holt JT . 1999 J. Biol. Chem. 274: 2732–2742

  • Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF . 2000 J. Neurochem. 74: 1951–1960

  • Auer K, Contessa J, Brenz-Verca S, Pirola L, Rusconi S, Cooper G, Abo A, Wymann M, Davis RJ, Birrer M, Dent P . 1998 Mol. Biol. Cell. 9: 561–573

  • Balaban N, Moni J, Shannon M, Dang L, Murphy E, Goldkorn T . 1996 Biochim. Biophys. Acta. 1314: 147–156

  • Barth RF . 1998 J. Neurooncol. 36: 91–102

  • Baselga J, Mendelson J, Kim Y-M, Pandiella A . 1996 J. Biol. Chem. 271: 3279–3284

  • Bishop MJ . 1991 Cell 64: 235–248

  • Cartee L, Vrana JA, Wang Z, Park JS, Birrer M, Fisher PB, Grant S, Dent P . 2000 Int. J. Oncol. 16: 413–422

  • Carter S, Auer KL, Birrer M, Fisher PB, Scmidtt-Ulrich R, Valerie K, Mikkelsen R, Dent P . 1998 Oncogene 16: 2787–2796

  • Chen BK, Chang WC . 2000 Proc. Natl. Acad. Sci. USA 97: 10406–10411

  • Chmura SJ, Mauceri HJ, Advani S, Heimann R, Nodzenski E, Quintans J, Kufe DW, Weichselbaum RR . 1997 Cancer Res. 57: 4340–4347

  • Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE . 1999 J. Biol. Chem. 274: 33709–33713

  • Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K, Schmidt-Ulrich R . 1999 Mol. Biol. Cell 11: 2493–2506

  • Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM . 1998 J. Biol. Chem. 273: 18623–18632

  • Fisher PB . 1984 Tumor Promotion and Cocarcinogenesis In Vitro, Mechanisms of Tumor Promotion. Slaga TJ (ed) CRC Press Inc., Boca Raton, FL. pp. 57–123

  • Gokhale PC, McRae D, Monia BP, Bagg A, Rahman A, Dritschilo A, Kasid U . 1999 Antisense Nucleic Acid Drug Dev. 9: 191–201

  • Goldkorn T, Balaban N, Shannon M, Matsukuma K . 1997 Biochim. Biophys. Acta. 1358: 289–299

  • Gupta AK, Bernhard EJ, Bakanauskas VJ, Wu JM, Muschel RJ, McKenna WG . 2000 Radiation Res. 154: 64–72

  • Hagan M, Wang L, Hanley JR, Park JS, Dent P . 2000 Radiation Res. 153: 371–383

  • Hossain MA, Christopher ML, Bouton CML, Jonathan Pevsner J, Laterra JC . 2000 J. Biol. Chem. 275: 27874–27882

  • Huhn SL, Mohapatra G, Bollen A, Lamborn K, Prados MD, Feuerstein BG . 1999 Clin. Cancer Res. 5: 1435–1443

  • Kang DC, LaFrance R, Su ZZ, Fisher PB . 1998 Proc. Natl. Acad. Sci. USA 95: 13788–13793

  • Kavanagh B, Dent P, Schmidt-Ullrich R, Chen P, Mikkelsen R . 1998 Radiation Res. 149: 579–587

  • Kraus JA, Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Muller B, Heuser K, Reifenberger G, Schlegel U . 2000 J. Neurol. 247: 455–460

  • Levenson AS, Tonetti DA, Jordan VC . 1998 Br. J. Cancer 77: 1812–1819

  • Li Z, Shimada Y, Uchida S, Maeda M, Kawabe A, Mori A, Itami A, Kano M, Watanabe G, Imamura M . 2000 Int. J. Oncol. 17: 453–460

  • Mazure NM, Chen EY, Laderoute KR, Giaccia AJ . 1997 Proc. Natl. Acad. Sci. USA 90: 3322–3331

  • Minet E, Ernest I, Michel G, Roland I, Remacle J, Raes M, Michiels C . 1999 Biochem. Biophys. Res. Commun. 261: 534–540

  • Pages G, Milanini J, Richard DE, Berra E, Gothie E, Vinals F, Pouyssegur J . 2000 Ann. N. Y. Acad. Sci. 902: 187–200

  • Park JS, Carter S, Reardon DB, Schmidt-Ullrich RK, Fisher PB, Dent P . 1999 Mol. Biol. Cell 10: 4231–4246

  • Park JS, Qiao L, Gilfor D, Hyelomon PB, Darlington G, Firestone GL, Fisher PB, Dent P . 2000 Mol. Biol. Cell 12: 2915–2932

  • Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H . 1999 Cancer Res. 59: 227–233

  • Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J, Mansour SJ, Ahn NG, Kerbel RS . 2000 Cancer Res. 60: 490–498

  • Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Dent P, Schmidt-Ullrich RK . 1999 Oncogene 18: 4756–4766

  • Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M . 1996 J. Biol. Chem. 271: 28220–28228

  • Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnik R . 1996 Cell 86: 189–199

  • Schmidt-Ullrich RK, Valerie K, Chan W, Wazer DE, Lin PS . 1992 Int. J. Radiat. Biol. 61: 405–415

  • Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB . 1997 Oncogene 15: 1191–1197

  • Slevin M, Krupinski J, Slowik A, Rubio F, Szczudlik A, Gaffney J . 2000 Neuroreport 11: 2759–2764

  • Su ZZ, Shi Y, Fisher PB . 1997 Proc. Natl. Acad. Sci. USA 94: 9125–9130

  • Su ZZ, Goldstein NI, Jiang H, Wang MN, Duigou GJ, Young CS, Fisher PB . 1999 Proc. Natl. Acad. Sci. USA 96: 15115–15120

  • Su Z, Shi Y, Fisher PB . 2000 Oncogene 19: 3411–3421

  • Suy S, Anderson WB, Dent P, Chang E, Kasid U . 1997 Oncogene 15: 53–61

  • Vogelstein B, Kinzler KW . 1991 Trends Genet. 9: 138–141

  • Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . 1995 Science 270: 1326–1331

  • Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D, Giaccia AJ . 2000 Genes Dev. 14: 391–396

Download references

Acknowledgements

This research was supported in part by National Institute of Health Grants DK52875, GM31452 and CA35675, Department of Defense grant BC98-0148, the V Foundation, the Chernow Endowment and the Samuel Waxman Cancer Research Foundation. PB Fisher is the Michael and Stella Chernow Urological Cancer Research Scientist. D Hinman is the recipient of the Virginia Junior Academy of Sciences, American Cancer Society Award for the year 2000. P Dent thanks Dr K Valerie for assistance with culture of T9 and RT2 cells and Dr PS Lin for performing colonogenic survival assays.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, JS., Qiao, L., Su, ZZ. et al. Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene 20, 3266–3280 (2001). https://doi.org/10.1038/sj.onc.1204258

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204258

Keywords

This article is cited by

Search

Quick links